128 related articles for article (PubMed ID: 10484518)
1. Selective targeting of cyclooxygenase-2 reveals its role in renal medullary interstitial cell survival.
Hao CM; Kömhoff M; Guan Y; Redha R; Breyer MD
Am J Physiol; 1999 Sep; 277(3):F352-9. PubMed ID: 10484518
[TBL] [Abstract][Full Text] [Related]
2. Dehydration activates an NF-kappaB-driven, COX2-dependent survival mechanism in renal medullary interstitial cells.
Hao CM; Yull F; Blackwell T; Kömhoff M; Davis LS; Breyer MD
J Clin Invest; 2000 Oct; 106(8):973-82. PubMed ID: 11032857
[TBL] [Abstract][Full Text] [Related]
3. Opposite effects of cyclooxygenase-1 and -2 activity on the pressor response to angiotensin II.
Qi Z; Hao CM; Langenbach RI; Breyer RM; Redha R; Morrow JD; Breyer MD
J Clin Invest; 2002 Jul; 110(1):61-9. PubMed ID: 12093889
[TBL] [Abstract][Full Text] [Related]
4. Peroxisome proliferator-activated receptor delta activation promotes cell survival following hypertonic stress.
Hao CM; Redha R; Morrow J; Breyer MD
J Biol Chem; 2002 Jun; 277(24):21341-5. PubMed ID: 11927585
[TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory effect of two isoforms of COX in H. pylori-induced gastritis in mice: possible involvement of PGE2.
Tanigawa T; Watanabe T; Hamaguchi M; Sasaki E; Tominaga K; Fujiwara Y; Oshitani N; Matsumoto T; Higuchi K; Arakawa T
Am J Physiol Gastrointest Liver Physiol; 2004 Jan; 286(1):G148-56. PubMed ID: 12958020
[TBL] [Abstract][Full Text] [Related]
6. Participation of cyclooxygenase-1 in prostaglandin E2 release from synovitis tissue in primary osteoarthritis in vitro.
Knorth H; Dorfmüller P; Lebert R; Schmidt WE; Wittenberg RH; Heukamp M; Wiese M; Willburger RE
Osteoarthritis Cartilage; 2004 Aug; 12(8):658-66. PubMed ID: 15262246
[TBL] [Abstract][Full Text] [Related]
7. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
[TBL] [Abstract][Full Text] [Related]
8. Cloning, expression, and regulation of rabbit cyclooxygenase-2 in renal medullary interstitial cells.
Guan Y; Chang M; Cho W; Zhang Y; Redha R; Davis L; Chang S; DuBois RN; Hao CM; Breyer M
Am J Physiol; 1997 Jul; 273(1 Pt 2):F18-26. PubMed ID: 9249588
[TBL] [Abstract][Full Text] [Related]
9. Role of cyclooxygenase (COX)-1 and COX-2 inhibition in nonsteroidal anti-inflammatory drug-induced intestinal damage in rats: relation to various pathogenic events.
Tanaka A; Hase S; Miyazawa T; Ohno R; Takeuchi K
J Pharmacol Exp Ther; 2002 Dec; 303(3):1248-54. PubMed ID: 12438549
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of selective inhibition of canine cyclooxygenase 1 and 2 by carprofen and other nonsteroidal anti-inflammatory drugs.
Ricketts AP; Lundy KM; Seibel SB
Am J Vet Res; 1998 Nov; 59(11):1441-6. PubMed ID: 9829404
[TBL] [Abstract][Full Text] [Related]
11. COX2 activity promotes organic osmolyte accumulation and adaptation of renal medullary interstitial cells to hypertonic stress.
Moeckel GW; Zhang L; Fogo AB; Hao CM; Pozzi A; Breyer MD
J Biol Chem; 2003 May; 278(21):19352-7. PubMed ID: 12637551
[TBL] [Abstract][Full Text] [Related]
12. The effect of selective cyclooxygenase inhibitors on intestinal epithelial cell mitogenesis.
Erickson BA; Longo WE; Panesar N; Mazuski JE; Kaminski DL
J Surg Res; 1999 Jan; 81(1):101-7. PubMed ID: 9889067
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase 1 and 2 in rheumatic disease: implications for nonsteroidal anti-inflammatory drug therapy.
Spangler RS
Semin Arthritis Rheum; 1996 Aug; 26(1):435-46. PubMed ID: 8870111
[TBL] [Abstract][Full Text] [Related]
14. Function of cyclo-oxygenase-1 and cyclo-oxygenase-2 in the ductus arteriosus from foetal lamb: differential development and change by oxygen and endotoxin.
Coceani F; Ackerley C; Seidlitz E; Kelsey L
Br J Pharmacol; 2001 Jan; 132(1):241-51. PubMed ID: 11156583
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of cyclooxygenase 1- and 2-derived prostanoids in mouse kidney and aorta.
Qi Z; Cai H; Morrow JD; Breyer MD
Hypertension; 2006 Aug; 48(2):323-8. PubMed ID: 16801485
[TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase 2 pathway mediates IL-1beta regulation of IL-1alpha, -1beta, and IL-6 mRNA levels in Leydig cell progenitors.
Walch L; Morris PL
Endocrinology; 2002 Sep; 143(9):3276-83. PubMed ID: 12193539
[TBL] [Abstract][Full Text] [Related]
17. Comparative effects of selective cyclooxygenase 1 and cyclooxygenase 2 inhibitors on myeloperoxidase and 3 alpha-hydroxysteroid dehydrogenase.
Rider NL; Pinto D; Covington M; Orwat MJ; Giannaras J; Nurnberg S; Dowling R; Davis JP; Williams JM; Trzaskos JM; Copeland RA
J Enzyme Inhib; 1996; 10(2):73-9. PubMed ID: 8835932
[TBL] [Abstract][Full Text] [Related]
18. Involvement of cyclooxygenase-derived prostaglandin E2 and nitric oxide in the protection of rat pancreas afforded by low dose of lipopolysaccharide.
Jaworek J; Bonior J; Tomaszewska R; Jachimczak B; Kot M; Bielański W; Pawlik WW; Sendur R; Stachura J; Konturek PC; Konturek SJ
J Physiol Pharmacol; 2001 Mar; 52(1):107-26. PubMed ID: 11321505
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase 2 and the kidney.
Breyer MD; Harris RC
Curr Opin Nephrol Hypertens; 2001 Jan; 10(1):89-98. PubMed ID: 11195058
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays.
Riendeau D; Charleson S; Cromlish W; Mancini JA; Wong E; Guay J
Can J Physiol Pharmacol; 1997 Sep; 75(9):1088-95. PubMed ID: 9365818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]